Assessing Efficacy and Cost of Blood-Based Tests for Colorectal Cancer
Charles Turck, PharmD, BCPS, BCCCP
Samuel Muench, MD
Optimizing Nivolumab in NSCLC: Implications for Cost, Access, and Outcomes
Aline Fares, MD
Studying Carboplatin-Paclitaxel + Retifanlimab for Squamous Cell Carcinoma of the Anal Canal
Richard Kim, MD
Uncovering Unmet Needs in Squamous Cell Carcinoma of the Anal Canal Care
Bringing Cancer Care Home: How Subcutaneous Immunotherapy Can Help Ease the Burden
Jorge Nieva, MD
Early-Onset Endometrial Cancer: Bridging the Gap Between Age and Outcome
Investigating At-Home Subcutaneous Atezolizumab for NSCLC: An Ongoing Study
Overall Survival with Neoadjuvant Therapy in HNSCC: Examining Real-World Data
Vanessa Helou, MD
Stratifying ICI-P Risk in Non-Small Cell Lung Cancer with Genetic and Radiographic Markers
Evaluating Dato-DXd for EGFR-Mutated Advanced NSCLC: Data from a Pooled Analysis
Jacob Sands, MD
Elaine Shum, MD
Estelamari Rodriguez, MD, MPH
Personalizing Prostate Cancer Surveillance: Insights from Canary PASS
Lisa Newcomb, PhD
Evolving Strategies in Limited-Stage Small Cell Lung Cancer Management
Gerard A. Silvestri MD, MS, Master FCCP
Anurag Singh, MD
Adam H. Fox, MD, MSc
Mariam Alexander, MD, PhD
Redefining Risk in Endometrial Cancer: Recurrence Prediction with Machine Learning
Poster Pearl: Axatilimab’s Impact on Fibrosis-Dominant Organs in cGVHD
Daniel Wolff, MD
ADT Monotherapy for mHSPC: How to Identify the Right Patients
Daniel J. George, MD
Redefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.